Regucalcin (RGN), which has been shown to increase rat heart sarcoplasmic reticulum Ca2+-ATPase activity and ATP‐dependent Ca2+ uptake, is a key molecule in heart muscle cell regulation through Ca2+ signalling, and has been suggested to play a pathophysiological role in heart failure [63, 64]. The gene discussed is RGN; the disease is heart failure.